- Medistore
- Diagnostic tests
- Genetics
Genetics
Genetic testing involves the analysis of genetic material. It allows for the identification of genes, the analysis of their functions, and the predisposition to certain diseases or hereditary traits. These tests enable the diagnosis and treatment of many genetic diseases (including cancers) and the assessment of the risk of their occurrence in patients and their offspring.

Diagnostics of cystic fibrosis and other CFTR-related diseases - analysis of the p.Phe508del mutation of the CFTR gene and over 80 other mutations in exon 11
Analysis of p.Phe508del mutations in the CFTR gene and other mutations in the exon 11

Test on genetic predisposition for hemochromatosis (5 HFE gene mutations)
The test allows the determination of mutations within a gene that determines carrier or disease occurrence: H63D, C282Y, S65C, E168X and Q283P.

Assessment of genetic predisposition to estrogen-dependent cancer/HTGR/(BRCA1- 3 mutations) + (CHEK2-1 mutation)
Diagnosis of genetic predisposition to estrogen-dependent cancer /HTGR/ (BRCA1- 3 mutations) + (CHEK2-1 mutation)

Genetic evaluation of karyotype in peripheral blood lymphocytes
Genetic karyotype assessment in peripheral blood lymphocytes

Genetic diagnostics of celiac disease - identification of HLA haplotypes DQ2 and DQ8
Detection of alleles HLA-DQ2/DQ8 - diagnosis of susceptibility to celiac disease (visceral disease)

Assessment of genetic predisposition to prostate cancer (BRCA1-2 mutations) + (CHEK2-2 mutations) + (NBS1-1 mutation)
Check your risk of prostate cancer. Take care of yourself!

Assessment of the genetic predispositions to thrombosis: mutations of the prothrombin gene (factor II) and Leiden (factor V)
Thrombosis is the third most common cardiovascular condition
in Poland, next to heart attack and stroke. Every year it is contracted by
approximately 60. thousand Poles. Carrying out the test will determine the predisposition
genetic predisposition to the disease, so that appropriate prophylaxis can be implemented
prevention.

Genetic Predisposition Screening for colorectal cancer
Hereditary colorectal cancer. An assessment of genetic predispositions to colorectal cancer by means of state-of-the-art methods for DNA analysis (NGS – next-generation sequencing), guaranteeing high precision and reliability. An analysis of as many as 25 genes that increase the risk of the disease. Only 2 appointments in the Centre. Check whether or not you are in the risk group.